Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease

Clinical and Experimental Immunology

Volumn 150, Issue 1, 2007, Pages 83-90

  Breunis, W B ^a,b,c   Biezeveld, M H ^a   Geissler, J ^b,c   Kuipers, I M ^a   Lam, J ^a   Ottenkamp, J ^a,d   Hutchinson, A ^e   Welch, R ^e   Chanock, S J ^f   Kuijpers, T W ^a,b,c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SAIC FREDERICK INC   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Chemokine receptor; Chemokines; Kawasaki disease; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GENOMIC DNA; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG MEGADOSE; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 3; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 34548540394     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03457.x     Document Type: Article

References (43)

1. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004 364:533 44.
2. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967 16:178 222.
3. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 110:2747 71.
4. Zhang T, Yanagawa H, Oki I, Nakamura Y. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr 2002 91:517 20.
5. Furukawa S, Matsubara T, Jujoh K et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988 48:247 51.
6. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992 121:924 6.
7. Maury CP, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med 1989 113:651 4.
8. Ueno Y, Takano N, Kanegane H et al. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989 76:337 42.
9. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000 122:514 19.
10. Wong M, Silverman ED, Fish EN. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease. J Rheumatol 1997 24:1179 85.
11. Terai M, Jibiki T, Harada A et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 1999 65:566 72.
12. Samson M, Soularue P, Vassart G, Parmentier M. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996 36:522 6.
13. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996 382:722 5.
14. Duncan SR, Scott S, Duncan CJ. Reappraisal of the historical selective pressures for the CCR5-{Delta}32 mutation. J Med Genet 2005 42:205 8.
15. Burns JC, Shimizu C, Gonzalez E et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005 192:344 9.
16. Fukunaga K, Asano K, Mao XQ et al. Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics. Eur Respir J 2001 17:59 63.
17. Faure S, Meyer L, Costagliola D et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000 287:2274 7.
18. Moatti D, Faure S, Fumeron F et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001 97:1925 8.
19. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo:Ministry of Health and Welfare, 1984.
20. Packer BR, Yeager M, Staats B et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004 32:D528 32 [database issue].
21. Benjamini Y, Hochberg Y. controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995 57:289 300.
22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 68:978 89.
23. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003 73:1162 9.
24. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002 70:425 34.
25. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997 277:959 65.
26. Abdi R, Tran TB, Sahagun-Ruiz A et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002 13:754 8.
27. Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997 186:1757 62.
28. Peters W, Dupuis M, Charo IF. A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J Immunol 2000 165:7072 7.
29. Peters W, Cyster JG, Mack M et al. CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J Immunol 2004 172:7647 53.
30. Galvani AP, Novembre J. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect 2005 7:302 9.
31. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DY. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 1988 7:863 6.
32. Burns JC, Shimizu C, Shike H et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 2005 6:438 44.
33. Matsubara T, Fujita Y, Sato T, Sasai K, Furukawa S. The prevalence of allergy in Kawasaki disease. Allergy 1998 53:815 16.
34. Matsubara T, Katayama K, Matsuoka T, Fujiwara M, Koga M, Furukawa S. Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol 1999 116:554 7.
35. Matsubara T, Ichiyama T, Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 2005 141:381 7.
36. Ohta K, Seno A, Shintani N et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993 152:647 9.
37. Terai M, Yasukawa K, Honda T et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J 2002 21:777 81.
38. Maho A, Bensimon A, Vassart G, Parmentier M. Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome. Cytogenet Cell Genet 1999 87:265 8.
39. Gao JL, Wynn TA, Chang Y et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997 185:1959 68.
40. Ness TL, Carpenter KJ, Ewing JL, Gerard CJ, Hogaboam CM, Kunkel SL. CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J Immunol 2004 173:6938 48.
41. Shang X, Qiu B, Frait KA et al. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol 2000 157:2055 63.
42. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004 95:858 66.
43. Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR. Genetic variations in CC chemokine receptors and hypertension. Am J Hypertens 2006 19:67 72.